CAR-T cell therapy is a promising treatment for multiple myeloma, especially for those with advanced or hard-to-treat cases. Here are some key points:

- Effectiveness: In clinical trials, 2 out of 3 participants were in remission for at least one year
- Side Effects: Common side effects include infections, muscle aches, Show Full Answer

CAR-T cell therapy is a promising treatment for multiple myeloma, especially for those with advanced or hard-to-treat cases. Here are some key points:

- Effectiveness: In clinical trials, 2 out of 3 participants were in remission for at least one year.
- Side Effects: Common side effects include infections, muscle aches, diarrhea, nausea, swelling, fever, cough, headache, and loss of appetite. Most side effects are mild, but serious ones can occur.
- Process: T cells are collected, genetically modified, and returned to the body to target cancer cells.
- Hospital Stay: Patients often need to stay in the hospital for several weeks post-treatment to monitor effectiveness and manage side effects.

Discuss thoroughly with your doctor to understand the risks and benefits specific to your condition.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Myeloma Treatments: Risks and Benefits | MyMyelomaTeam